Free Trial

Embecta (EMBC) Stock Price, News & Analysis

Embecta logo
$14.25 -0.05 (-0.35%)
Closing price 04:00 PM Eastern
Extended Trading
$13.94 -0.31 (-2.18%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Embecta Stock (NASDAQ:EMBC)

Advanced

Key Stats

Today's Range
$14.13
$14.55
50-Day Range
$13.35
$15.31
52-Week Range
$9.20
$21.48
Volume
261,040 shs
Average Volume
572,559 shs
Market Capitalization
$833.48 million
P/E Ratio
9.97
Dividend Yield
4.21%
Price Target
$19.00
Consensus Rating
Hold

Company Overview

Embecta Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
94th Percentile Overall Score

EMBC MarketRank™: 

Embecta scored higher than 94% of companies evaluated by MarketBeat, and ranked 61st out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Embecta has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 1 buy rating, 4 hold ratings, and no sell ratings.

  • Upside Potential

    Embecta has a consensus price target of $19.00, representing about 33.3% upside from its current price of $14.25.

  • Amount of Analyst Coverage

    Embecta has only been the subject of 3 research reports in the past 90 days.

  • Read more about Embecta's stock forecast and price target.
  • Earnings Growth

    Earnings for Embecta are expected to grow by 7.72% in the coming year, from $2.85 to $3.07 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Embecta is 9.97, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 79.41.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Embecta is 9.97, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.13.

  • Price to Earnings Growth Ratio

    Embecta has a PEG Ratio of 0.78. PEG Ratios below 1 indicate that a company could be undervalued.

  • Read more about Embecta's valuation and earnings.
  • Percentage of Shares Shorted

    4.58% of the float of Embecta has been sold short.
  • Short Interest Ratio / Days to Cover

    Embecta has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Embecta has recently decreased by 5.32%, indicating that investor sentiment is improving significantly.
  • Dividend Leadership

    Embecta is a leading dividend payer. It pays a dividend yield of 4.26%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Embecta does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Embecta is 41.96%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Embecta will have a dividend payout ratio of 19.54% next year. This indicates that Embecta will be able to sustain or increase its dividend.

  • Read more about Embecta's dividend.
  • Percentage of Shares Shorted

    4.58% of the float of Embecta has been sold short.
  • Short Interest Ratio / Days to Cover

    Embecta has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Embecta has recently decreased by 5.32%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Embecta has a news sentiment score of 1.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Embecta this week, compared to 4 articles on an average week.
  • Search Interest

    Only 1 people have searched for EMBC on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Embecta to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Embecta insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.42% of the stock of Embecta is held by insiders.

  • Percentage Held by Institutions

    93.83% of the stock of Embecta is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Embecta's insider trading history.
Receive EMBC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Embecta and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EMBC Stock News Headlines

This Crypto Is Set to Explode in January
Curious about crypto but still stuck scrolling endless threads? People who get in early aren’t just lucky—they understand the why, when, and how of crypto. Join our free 2‑day virtual summit and learn directly from the world’s top hedge fund managers who’ve built real portfolios and real wealth. You’ll walk away with actionable insights grounded in strategy—not hype. No FOMO. No fluff. Just clear steps to move from intrigued to informed about crypto.tc pixel
embecta to Participate in Investor Events
See More Headlines

EMBC Stock Analysis - Frequently Asked Questions

Embecta's stock was trading at $20.65 at the start of the year. Since then, EMBC shares have decreased by 31.0% and is now trading at $14.25.

Embecta Corp. (NASDAQ:EMBC) posted its earnings results on Friday, August, 8th. The company reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.35. Embecta's revenue for the quarter was up 8.4% compared to the same quarter last year.
Read the conference call transcript
.

Top institutional shareholders of Embecta include CWA Asset Management Group LLC (0.23%), Exchange Traded Concepts LLC (0.21%), Voya Investment Management LLC (0.15%) and North Star Investment Management Corp. (0.10%). Insiders that own company stock include Devdatt Kurdikar, David F Melcher, Jacob Elguicze, Jeffrey Z Mann and Milton Mayo Morris.
View institutional ownership trends
.

Shares of EMBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Embecta investors own include Waste Connections (WCN), AUO (AUOTY), The RMR Group (RMR), DiamondRock Hospitality (DRH), American Water Works (AWK), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
8/08/2025
Record date for 9/15 Dividend
8/29/2025
Ex-Dividend for 9/15 Dividend
8/29/2025
Dividend Payable
9/15/2025
Today
10/22/2025
Next Earnings (Estimated)
11/25/2025
Fiscal Year End
9/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:EMBC
CIK
1872789
Fax
N/A
Employees
2,100
Year Founded
N/A

Price Target and Rating

High Price Target
$25.00
Low Price Target
$12.00
Potential Upside/Downside
+31.6%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.43
Trailing P/E Ratio
10.10
Forward P/E Ratio
5.07
P/E Growth
0.78
Net Income
$78.30 million
Net Margins
7.58%
Pretax Margin
9.10%
Return on Equity
-23.40%
Return on Assets
14.46%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.47
Quick Ratio
1.78

Sales & Book Value

Annual Sales
$1.12 billion
Price / Sales
0.75
Cash Flow
$3.41 per share
Price / Cash Flow
4.23
Book Value
($12.80) per share
Price / Book
-1.13

Miscellaneous

Outstanding Shares
58,490,000
Free Float
58,239,000
Market Cap
$844.71 million
Optionable
Optionable
Beta
1.10
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:EMBC) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners